XENE
Xenon Pharmaceuticals Inc
36.90$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6,905.6% | – | – | – | – | – | – | – | – | – | – | |
| – | +40.7% | -16.8% | -24.9% | -9.7% | -26.8% | +50.1% | +40.7% | +79.2% | +118.0% | -27.7% | -0.7% | |
| – | +390.7% | -42.0% | +3.5% | +17.4% | +11.4% | +94.2% | +76.4% | +103.4% | +58.9% | +56.7% | +5.9% | |
| – | +1,279.6% | -92.4% | -4.5% | -247.9% | – | +138.7% | +87.2% | +107.4% | – | – | – | |
| – | – | – | -68.6% | -94.6% | +111,633.3% | -177.8% | – | – | – | +1.4% | -23.7% | |
| – | -64.0% | -49.4% | +12.9% | +61.0% | +144.6% | +112.7% | -22.3% | +41.2% | +94.1% | -45.3% | -74.0% | |
| – | – | -569.3% | – | -219.3% | +128.7% | -74.6% | +1,366.8% | +20.0% | -60.4% | – | +32.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.3% | +8,520.1% | -99.3% | +58,170.1% | -73.3% | +272.6% | -99.7% | +171.2% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +22.6% | -298.1% | +0.0% | -100.0% | – | – | – | – | |
| – | -99.3% | +8,520.1% | -70.5% | +1,478.4% | -75.3% | +211.8% | +421.6% | -37.8% | +27.0% | -96.6% | +865.5% | |
| – | -139.3% | – | – | +1,293.9% | -191.0% | – | +545.2% | -190.6% | – | -106.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.